Archive - July 2018
NHS England says yes to Roche’s Hemlibra
Axovant licenses another gene therapy as new strategy beds in
Communiqué: big wins for obesity and sugar tax campaigners
Abingworth raises $315m to expand hunt for promising biotechs
NHS England clears specialised treatments for NHS use
Vertex, NHS England no closer to Orkambi settlement
China vows to slash cancer drug prices
PAH patients in England denied access to Actelion’s Uptravi on NHS